1st Quarter - Report
DARLENE RICHESON & ASSOCIATES for JOHNSON & JOHNSON
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5629 Pathways for Biosimilars Act of 2008 ; all provisions H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007; all provisions FDA Appropriations HIV/AIDS
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARLENE P RICHESON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.